Twist Bioscience CorporationTWSTNASDAQ
LOADING
|||
Cash Flow Performance
Above historical average, modest growth trend.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-75.63M
↑ 32% above average
Average (9y)
$-110.80M
Historical baseline
Range
High:$-44.82M
Low:$-226.24M
CAGR
+6.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | $-75.63M | -9.3% |
| 2024 | $-69.17M | +59.4% |
| 2023 | $-170.25M | +24.7% |
| 2022 | $-226.24M | -62.4% |
| 2021 | $-139.31M | +8.4% |
| 2020 | $-152.12M | -48.1% |
| 2019 | $-102.69M | -47.0% |
| 2018 | $-69.85M | -20.7% |
| 2017 | $-57.90M | -29.2% |
| 2016 | $-44.82M | - |